Corazon Capital V838 Monoceros Corp Warrant
CRZNW
CRZNW was delisted on the 22nd of March, 2023.
0 hedge funds and large institutions have $0 invested in Corazon Capital V838 Monoceros Corp Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
100% less funds holding
Funds holding: 29 → 0 (-29)
100% less capital invested
Capital invested by funds: $1.4M → $0 (-$1.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 29
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$841K |
| 2 |
AGC
Angelo Gordon & Co
New York
|
-$504K |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.5K |
| 4 |
SC
Sculptor Capital
New York
|
-$5.1K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
-$5.09K |
CRZNW Hedge Fund Activity: Q1 2023 in Review
0 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Corazon Capital V838 Monoceros Corp Warrant (CRZNW) for Q1 2023, worth a combined $0 — down 100% from $1.4M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CRZNW and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $841K sold.
- 0 institutional investors held Corazon Capital V838 Monoceros Corp Warrant (CRZNW) as of Q1 2023, down from 29 in Q4 2022.
- Funds reported $0 of Corazon Capital V838 Monoceros Corp Warrant stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Corazon Capital V838 Monoceros Corp Warrant positions in Q1 2023 and 29 closed out, a net change of -29 holders.
- The largest Corazon Capital V838 Monoceros Corp Warrant seller in Q1 2023 was Radcliffe Capital Management, an estimated $841K sold.
Based on aggregated 13F filings for Q1 2023.